Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Utility of Plasma Circulating Tumor DNA (ctDNA) Measurements for the Detection of Colon Cancer in Patients Undergoing Diagnostic Colonoscopy

NCT02665299 is registered in ClinicalTrials.gov with Pathway Genomics as lead sponsor.

NCT NCT02665299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02665299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Utility of Plasma Circulating Tumor DNA (ctDNA) Measurements for the Detection of Colon Cancer in Patients Undergoing Diagnostic Colonoscopy
Lead sponsor
Pathway Genomics
Phase
Observational
Overall status
Completed
Start date
January 31, 2016
Completion date
August 31, 2017
Enrollment
206 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon adenomas, colon cancer, colon polyps